Saudi Biotechnology Accelerator Participating in WHX Dubai 2026
Explore Saudi opportunities in biotech and health innovation
Saudi Biotechnology Accelerator (SBA) will participate in WHX Dubai 2026 (formerly Arab Health), 09–12 February 2026, to present Saudi Arabia’s expanding biotechnology, healthtech, and medtech innovation landscape and to engage with global partners shaping the future of life sciences.
At WHX Dubai, SBA will showcase its national platform designed to prepare, validate, and grow biotechnology and deep-tech innovation ventures within Saudi Arabia.
Interested partners will learn how SBA’s flagship programs – the Biotechnology Venture Readiness Program (BVRP), the Research, Trial & Pilot Project Program (RTPP), and the Biotech Growth Accelerator Program (BGAP), and the upcoming initiative of establishing the Biotechnology Innovation Production Hub (BIPH) – form a continuous pathway from scientific innovation to venture creation, research execution, clinical validation, industrial translation, and investment readiness.
International Startups will discover how SBA supports market entry and ecosystem integration in Saudi Arabia.
Investors and industry partners will explore co-development, pilot, scale-up, and commercialization opportunities.
Research institutions and healthcare organizations will engage in building cross-border collaboration in clinical trials, data platforms, and translational science.
Government and ecosystem leaders will see how SBA contributes to national biotech capacity building and talent development.
We welcome innovators, investors, research leaders, healthcare institutions, and industry partners to meet us at WHX Dubai and explore how global science connects with Saudi opportunity.
Saudi Biotechnology Accelerator
Pioneering Riyadh-based Saudi Biotechnology Accelerator, advancing biotech, healthtech and life sciences innovators’ journey, and helping to excel in the markets, while actively contributing to the Saudi innovation ecosystem